Susan R Ross Selected Research

Cytidine

1/2020	Murine Leukemia Virus P50 Protein Counteracts APOBEC3 by Blocking Its Packaging.
1/2018	Deaminase-Dead Mouse APOBEC3 Is an In Vivo Retroviral Restriction Factor.
11/2015	APOBEC3 Proteins in Viral Immunity.
5/2013	APOBEC3 inhibition of mouse mammary tumor virus infection: the role of cytidine deamination versus inhibition of reverse transcription.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Susan R Ross Research Topics

Disease

30	Infections 10/2021 - 01/2002
7	Neoplasms (Cancer) 12/2021 - 02/2002
5	Retroviridae Infections (Infection, Retrovirus) 01/2020 - 05/2003
4	Virus Diseases (Viral Diseases) 01/2019 - 11/2008
3	Bites and Stings (Sting) 01/2022 - 04/2015
3	Vesicular Stomatitis 01/2021 - 09/2002
3	Breast Neoplasms (Breast Cancer) 01/2016 - 02/2005
2	Fever (Fevers) 01/2019 - 02/2008
2	Carcinogenesis 09/2006 - 04/2006
1	DNA Virus Infections 01/2022
1	Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy) 01/2019
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2017
1	Autoimmune Diseases (Autoimmune Disease) 01/2017
1	Lymphoma (Lymphomas) 01/2016
1	American Hemorrhagic Fever (Bolivian Hemorrhagic Fever) 07/2014
1	Neuralgia (Stump Neuralgia) 09/2013
1	Starvation 12/2012
1	Carcinoma (Carcinomatosis) 02/2002

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 10/2021 - 02/2002
6	Antiviral Agents (Antivirals)IBA 12/2020 - 05/2013
5	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2017
4	Glycoproteins (Glycoprotein)IBA 01/2021 - 05/2003
4	CytidineIBA 01/2020 - 05/2013
3	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2020 - 09/2003
3	CytokinesIBA 01/2017 - 07/2014
3	Transferrin Receptors (Transferrin Receptor)IBA 02/2008 - 09/2002
2	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2022 - 01/2017
2	Interferon Type IIBA 01/2022 - 01/2018
2	Cytidine DeaminaseIBA 12/2021 - 01/2018
2	VaccinesIBA 01/2021 - 09/2013
2	Nucleic AcidsIBA 01/2020 - 01/2018
2	ApolipoproteinsIBA 01/2020 - 11/2015
2	RNA (Ribonucleic Acid)IBA 01/2018 - 04/2009
2	Retroelements (Retrotransposon)IBA 01/2017 - 11/2015
2	Pharmaceutical PreparationsIBA 09/2013 - 12/2012
2	Membrane Proteins (Integral Membrane Proteins)IBA 08/2011 - 05/2003
2	Tyrosine (L-Tyrosine)FDA Link 09/2006 - 04/2006
1	Single-Stranded DNA (DNA, Single Stranded)IBA 01/2022
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 12/2021
1	APOBEC-1 DeaminaseIBA 10/2021
1	CytosineIBA 12/2020
1	Peptides (Polypeptides)IBA 01/2020
1	EnzymesIBA 01/2020
1	1-(carboxymethylthio)tetradecaneIBA 01/2019
1	Tripartite Motif ProteinsIBA 01/2019
1	Antiviral Restriction FactorsIBA 01/2018
1	Viral RNAIBA 01/2018
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2018
1	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2017
1	Pattern Recognition ReceptorsIBA 01/2017
1	InterferonsIBA 01/2017
1	Caspase 9IBA 05/2016
1	ZCL278IBA 05/2016
1	Monomeric GTP-Binding ProteinsIBA 05/2016
1	human APOBEC3 proteinsIBA 01/2016
1	Transcription Factors (Transcription Factor)IBA 04/2015
1	Toll-Like Receptor 2IBA 07/2014
1	Gabapentin (Neurontin)FDA LinkGeneric 09/2013
1	LipopolysaccharidesIBA 04/2009
1	vesicular stomatitis virus G proteinIBA 04/2009
1	Green Fluorescent ProteinsIBA 03/2009
1	CathepsinsIBA 11/2008
1	SuperantigensIBA 08/2008
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 09/2006
1	env Gene ProductsIBA 09/2006
1	Oncogene Proteins (Oncogene Protein)IBA 02/2005
1	AntigensIBA 08/2004
1	Heparitin Sulfate (Heparan Sulfate)IBA 10/2003
1	Amino Acids FDA Link 05/2003
1	AcidsIBA 09/2002
1	Monoclonal AntibodiesIBA 09/2002
1	Interleukin-12 (IL 12)IBA 02/2002
1	Antineoplastic Agents (Antineoplastics)IBA 02/2002
1	Integrin beta1IBA 01/2002
1	L-SelectinIBA 01/2002
1	integrin beta7IBA 01/2002

Therapy/Procedure

1	Therapeutics 02/2002